MacuHealth News
Print this Article | Send to Colleague
MacuHealth News
How Does Working with MacuHealth Benefit Optometry Students?
Determining the quality of a patient's vision and detecting any signs of visual diseases are some of the invaluable skills students will learn when attending optometry school. But what can they learn about their upcoming careers from an eye supplement company?
MacuHealth believes it has a lot to offer future optometrists. The company has sponsored several Continuing Education courses this year. Additionally, its Chief Scientific Officer, Dr. Jim Stringham, has been holding engaging and informative seminars at schools for student groups across the nation on how proper nutrition can affect vision, an often-overlooked part of the optometry curriculum.
Any optometric advancement must have the research to back it up, and students need to know how to discern poor science from peer-reviewed investigations so they can confidently use this information to make decisions for the care of their patients. Numerous gold-standard studies published in scientific journals confirm the effectiveness of MacuHealth's line of supplements. The company's trained sales team can show future optometrists how to share this research with patients.
And speaking of MacuHealth's sales specialists, they're available to help students and doctors learn the business side of optometry. They specialize in training staff on integrating each supplement into the patient experience, including MacuHealth's Triple Carotenoid Formula, the AREDS2-based MacuHealth Plus+, TG Omega-3 fish oil, the sports supplement Vision Edge ECP and VitreousHealth, the first science-based eye floater treatment.
Would you like to learn more about how MacuHealth can help your students or organization? Please email Emily Blum at eblum@macuhealth.com for details. We offer informative lectures with Chief Scientific Officer Dr. Jim Stringham, and any member of our sales team can give a non-branded presentation on the importance of eye nutrition to any size audience.